Cargando…

Symptomatology, prognosis and clinical findings of STEMI as a ramification of COVID-19: A systematic review and proportion meta-analysis()

BACKGROUND: There is an increasing COVID-19 population with concurrent STEMI. SARS-CoV-2 poses a significant risk of hypercoagulable and/or prothrombotic events due to the disturbance in hemostasis by affecting all three components of the Virchow's triad. These abnormalities in hemostasis are a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaiswal, Vikash, Almas, Talal, Peng Ang, Song, David Song, Shama, Nishat, Storozhenko, Tatyana, Lnu, Kriti, Parmar, Garima, Qaiser, Saria, Naz, Sidra, Jaiswal, Akash, Malik, Jahanzeb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902059/
https://www.ncbi.nlm.nih.gov/pubmed/35284069
http://dx.doi.org/10.1016/j.amsu.2022.103429
_version_ 1784664510060036096
author Jaiswal, Vikash
Almas, Talal
Peng Ang, Song
David Song
Shama, Nishat
Storozhenko, Tatyana
Lnu, Kriti
Parmar, Garima
Qaiser, Saria
Naz, Sidra
Jaiswal, Akash
Malik, Jahanzeb
author_facet Jaiswal, Vikash
Almas, Talal
Peng Ang, Song
David Song
Shama, Nishat
Storozhenko, Tatyana
Lnu, Kriti
Parmar, Garima
Qaiser, Saria
Naz, Sidra
Jaiswal, Akash
Malik, Jahanzeb
author_sort Jaiswal, Vikash
collection PubMed
description BACKGROUND: There is an increasing COVID-19 population with concurrent STEMI. SARS-CoV-2 poses a significant risk of hypercoagulable and/or prothrombotic events due to the disturbance in hemostasis by affecting all three components of the Virchow's triad. These abnormalities in hemostasis are an increased risk factor for cardiovascular events, including acute thrombotic occlusion of coronary arteries leading to myocardial infarction. OBJECTIVE: The objective of this study is to collate the prognosis, symptomatology and clinical findings of COVID-19 adverse events causing STEMI. METHODS: Databases were queried with various keyword combinations to find applicable articles. Cardiovascular risk factors, symptomatology, mortality and rates of PCI were analyzed using random-effect model. RESULTS: 15 studies with a total of 379 patients were included in the final analysis. Mean age of patients was 62.82 ± 36.01, with a male predominance (72%, n = 274). Hypertension, dyslipidemia and diabetes mellitus were the most common cardiovascular risk factors among these patients, with a pooled proportion of 72%, 59% and 40% respectively. Dyspnea (61%, n = 131) was the most frequent presenting symptom, followed by chest pain (60%, n = 101) and fever (56%, n = 104). 62% of the patients had obstructive CAD during coronary angiography. The primary reperfusion method used in the majority of cases was percutaneous coronary intervention (64%, n = 124). Mortality, which is the primary outcome in our study, was relatively high, with a rate of 34% across studies. CONCLUSION: Our findings show that most cases have been found in males, while the most common risk factors were Hypertension and Diabetes Mellitus. In most COVID-19 cases with ST-segment myocardial infarction, most hospitalized patients underwent primary percutaneous coronary intervention instead of fibrinolysis. The in-hospital mortality was significantly higher, making this report significant. As the sample size and reported study are considerably less, it warrants a further large-scale investigation to generalize it.
format Online
Article
Text
id pubmed-8902059
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-89020592022-03-08 Symptomatology, prognosis and clinical findings of STEMI as a ramification of COVID-19: A systematic review and proportion meta-analysis() Jaiswal, Vikash Almas, Talal Peng Ang, Song David Song Shama, Nishat Storozhenko, Tatyana Lnu, Kriti Parmar, Garima Qaiser, Saria Naz, Sidra Jaiswal, Akash Malik, Jahanzeb Ann Med Surg (Lond) Systematic Review / Meta-analysis BACKGROUND: There is an increasing COVID-19 population with concurrent STEMI. SARS-CoV-2 poses a significant risk of hypercoagulable and/or prothrombotic events due to the disturbance in hemostasis by affecting all three components of the Virchow's triad. These abnormalities in hemostasis are an increased risk factor for cardiovascular events, including acute thrombotic occlusion of coronary arteries leading to myocardial infarction. OBJECTIVE: The objective of this study is to collate the prognosis, symptomatology and clinical findings of COVID-19 adverse events causing STEMI. METHODS: Databases were queried with various keyword combinations to find applicable articles. Cardiovascular risk factors, symptomatology, mortality and rates of PCI were analyzed using random-effect model. RESULTS: 15 studies with a total of 379 patients were included in the final analysis. Mean age of patients was 62.82 ± 36.01, with a male predominance (72%, n = 274). Hypertension, dyslipidemia and diabetes mellitus were the most common cardiovascular risk factors among these patients, with a pooled proportion of 72%, 59% and 40% respectively. Dyspnea (61%, n = 131) was the most frequent presenting symptom, followed by chest pain (60%, n = 101) and fever (56%, n = 104). 62% of the patients had obstructive CAD during coronary angiography. The primary reperfusion method used in the majority of cases was percutaneous coronary intervention (64%, n = 124). Mortality, which is the primary outcome in our study, was relatively high, with a rate of 34% across studies. CONCLUSION: Our findings show that most cases have been found in males, while the most common risk factors were Hypertension and Diabetes Mellitus. In most COVID-19 cases with ST-segment myocardial infarction, most hospitalized patients underwent primary percutaneous coronary intervention instead of fibrinolysis. The in-hospital mortality was significantly higher, making this report significant. As the sample size and reported study are considerably less, it warrants a further large-scale investigation to generalize it. Elsevier 2022-03-08 /pmc/articles/PMC8902059/ /pubmed/35284069 http://dx.doi.org/10.1016/j.amsu.2022.103429 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review / Meta-analysis
Jaiswal, Vikash
Almas, Talal
Peng Ang, Song
David Song
Shama, Nishat
Storozhenko, Tatyana
Lnu, Kriti
Parmar, Garima
Qaiser, Saria
Naz, Sidra
Jaiswal, Akash
Malik, Jahanzeb
Symptomatology, prognosis and clinical findings of STEMI as a ramification of COVID-19: A systematic review and proportion meta-analysis()
title Symptomatology, prognosis and clinical findings of STEMI as a ramification of COVID-19: A systematic review and proportion meta-analysis()
title_full Symptomatology, prognosis and clinical findings of STEMI as a ramification of COVID-19: A systematic review and proportion meta-analysis()
title_fullStr Symptomatology, prognosis and clinical findings of STEMI as a ramification of COVID-19: A systematic review and proportion meta-analysis()
title_full_unstemmed Symptomatology, prognosis and clinical findings of STEMI as a ramification of COVID-19: A systematic review and proportion meta-analysis()
title_short Symptomatology, prognosis and clinical findings of STEMI as a ramification of COVID-19: A systematic review and proportion meta-analysis()
title_sort symptomatology, prognosis and clinical findings of stemi as a ramification of covid-19: a systematic review and proportion meta-analysis()
topic Systematic Review / Meta-analysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902059/
https://www.ncbi.nlm.nih.gov/pubmed/35284069
http://dx.doi.org/10.1016/j.amsu.2022.103429
work_keys_str_mv AT jaiswalvikash symptomatologyprognosisandclinicalfindingsofstemiasaramificationofcovid19asystematicreviewandproportionmetaanalysis
AT almastalal symptomatologyprognosisandclinicalfindingsofstemiasaramificationofcovid19asystematicreviewandproportionmetaanalysis
AT pengangsong symptomatologyprognosisandclinicalfindingsofstemiasaramificationofcovid19asystematicreviewandproportionmetaanalysis
AT davidsong symptomatologyprognosisandclinicalfindingsofstemiasaramificationofcovid19asystematicreviewandproportionmetaanalysis
AT shamanishat symptomatologyprognosisandclinicalfindingsofstemiasaramificationofcovid19asystematicreviewandproportionmetaanalysis
AT storozhenkotatyana symptomatologyprognosisandclinicalfindingsofstemiasaramificationofcovid19asystematicreviewandproportionmetaanalysis
AT lnukriti symptomatologyprognosisandclinicalfindingsofstemiasaramificationofcovid19asystematicreviewandproportionmetaanalysis
AT parmargarima symptomatologyprognosisandclinicalfindingsofstemiasaramificationofcovid19asystematicreviewandproportionmetaanalysis
AT qaisersaria symptomatologyprognosisandclinicalfindingsofstemiasaramificationofcovid19asystematicreviewandproportionmetaanalysis
AT nazsidra symptomatologyprognosisandclinicalfindingsofstemiasaramificationofcovid19asystematicreviewandproportionmetaanalysis
AT jaiswalakash symptomatologyprognosisandclinicalfindingsofstemiasaramificationofcovid19asystematicreviewandproportionmetaanalysis
AT malikjahanzeb symptomatologyprognosisandclinicalfindingsofstemiasaramificationofcovid19asystematicreviewandproportionmetaanalysis